TN2013000265A1 - Anti-cd38 antibodies - Google Patents
Anti-cd38 antibodiesInfo
- Publication number
- TN2013000265A1 TN2013000265A1 TNP2013000265A TN2013000265A TN2013000265A1 TN 2013000265 A1 TN2013000265 A1 TN 2013000265A1 TN P2013000265 A TNP2013000265 A TN P2013000265A TN 2013000265 A TN2013000265 A TN 2013000265A TN 2013000265 A1 TN2013000265 A1 TN 2013000265A1
- Authority
- TN
- Tunisia
- Prior art keywords
- antibodies
- disclosed
- cynomolgus
- bind
- therapeutic
- Prior art date
Links
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 abstract 2
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 102000052645 human CD38 Human genes 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161485104P | 2011-05-11 | 2011-05-11 | |
| PCT/US2011/068235 WO2012092612A1 (en) | 2010-12-30 | 2011-12-30 | Anti-cd38 antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2013000265A1 true TN2013000265A1 (en) | 2014-11-10 |
Family
ID=54359573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2013000265A TN2013000265A1 (en) | 2011-05-11 | 2013-06-21 | Anti-cd38 antibodies |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2013000265A1 (en) |
-
2013
- 2013-06-21 TN TNP2013000265A patent/TN2013000265A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020012426A (en) | Anti-cd38 antibodies. | |
| PH12014502406A1 (en) | Anti-il-23p19 antibodies | |
| PH12014501108A1 (en) | Anti-il-36r antibodies | |
| MX350200B (en) | Human antibodies and antibody-drug conjugates against cd74. | |
| PH12013500810B1 (en) | Anti-il-23 antibodies | |
| MY155950A (en) | Anti-cd40 antibodies | |
| PH12012501793B1 (en) | Monoclonal antibodies against c-met | |
| PH12013500955A1 (en) | Spiro-oxindole mdm2 antagonists | |
| MX346375B (en) | Spiro-oxindole mdm2 antagonists. | |
| MX347734B (en) | S100a4 antibodies and therapeutic uses thereof. | |
| SG194701A1 (en) | Anti-cd40 antibodies and methods of use | |
| NZ707086A (en) | Anti-cd40 antibodies and methods of use | |
| MX349004B (en) | New compounds. | |
| SG184310A1 (en) | Antibodies that bind human cd27 and uses thereof | |
| MX2014004074A (en) | Methods of treating liver conditions using notch2 antagonists. | |
| TN2013000265A1 (en) | Anti-cd38 antibodies | |
| PH12013501424B1 (en) | Anti-cd38 antibodies | |
| TN2013000186A1 (en) | Anti-il-23 antibodies | |
| TN2014000207A1 (en) | Anti il-36r antibodies | |
| TN2013000202A1 (en) | Spiro-oxindole mdm2 antagonists |